This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arrayit Corporation Selected By Silicom Ventures To Present At The 2010 Personalized Medicine World Conference In Silicon Valley

SUNNYVALE, Calif., Jan. 19 /PRNewswire-FirstCall/ -- Arrayit Corporation (OTC Bulletin Board: ARYC), a life sciences-focused healthcare company, today announced that the Company has been selected to present at the PMWC 2010 Personalized Medicine Conference in Silicon Valley, California.

Personalized Medicine focuses on the use of a patient's clinical, genetic, genomic and environmental information to select a medication and determine optimal dosage, or to choose a therapy, or recommend preventative health measures.  The goal of Personalized Medicine is to optimize the healthcare and medical outcomes for each individual.  

PMWC's technology showcase will feature selected companies recognized for their breakthrough products and services.  The "TOP 5" presenters will move to a semi-final stage to compete for the "PMWC 2010 Most Promising Company Award."  The event is being hosted by Silicom Ventures, one of the largest angel and venture capitalist investment forums and funds in the United States, and will take place on January 19-20, 2010.  

Arrayit founder and Executive Vice President Todd Martinsky will present the Company's growth strategy, which includes the development of new microarray-based pre-symptomatic tests for the diagnosis of Ovarian Cancer ( OvaDx ), Parkinson's Disease and Prostate Cancer.  The Company will market and sell its diagnostic tests through its subsidiary, Arrayit Diagnostics, Inc.

About Arrayit Diagnostics, Inc.

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation, is actively engaged in developing and commercializing a series of proprietary microarray-based diagnostic tests that provide for early detection of cancers, neurodegenerative diseases and other chronic and severe disease states.

About Arrayit Corporation

Arrayit Corporation leads and empowers the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.  It now offers over 650 products to a customer base of more than 10,000 laboratories worldwide, including almost every major university, pharmaceutical and biotechnology company, major agricultural and chemical companies, government agencies, national research foundations and many private sector enterprises.  Please visit for more information.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ARYC $0.00 33.33%
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs